logo
Book a meeting
Phoenix Nest

Phoenix Nest

Biotechnology, 254 36th St Ste B631, Brooklyn, New York, 11232, United States, 11-50 Employees

phoenixnestbiotech.com

  • LinkedIn

phone no Phone Number: 91********

Who is PHOENIX NEST

Phoenix Nest is a collaborative company focused on treating Sanfilippo Syndrome (Mucopolysaccharidosis (MPS) IIIB, IIIC and IIID). Our goal is to bring these treatments to market as quick...

Read More

lock icon Get Full Access
map
  • 254 36th St Ste B631, Brooklyn, New York, 11232, United States Headquarters: 254 36th St Ste B631, Brooklyn, New York, 11232, United States
  • 2012 Date Founded: 2012
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies
  • Jill Wood CEO:   Jill Wood

industries-icon Industry: Biotechnology

SIC SIC Code: 2836 | NAICS Code: 541714 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from PHOENIX NEST

Phoenix Nest Org Chart and Mapping

Jill Wood

Jill Wood

CEO & Co-Founder Phoenix Nest Inc.

Employees
Jennifer Lusch

Jennifer Lusch

Owner

Srikanth Singamsetty

Srikanth Singamsetty

Scientific Director

See Full Org Chart arrow
email-formate-icon
View Email Formats for Phoenix Nest
arrow
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

Join Now

crown-icon Free credits every month

Frequently Asked Questions Regarding Phoenix Nest

Answer: Phoenix Nest's headquarters are located at 254 36th St Ste B631, Brooklyn, New York, 11232, United States

Answer: Phoenix Nest's phone number is 91********

Answer: Phoenix Nest's official website is https://phoenixnestbiotech.com

Answer: Phoenix Nest's revenue is $1 Million to $5 Million

Answer: Phoenix Nest's SIC: 2836

Answer: Phoenix Nest's NAICS: 541714

Answer: Phoenix Nest has 11-50 employees

Answer: Phoenix Nest is in Biotechnology

Answer: Phoenix Nest contact info: Phone number: 91******** Website: https://phoenixnestbiotech.com

Answer: Phoenix Nest is a collaborative company focused on treating Sanfilippo Syndrome (Mucopolysaccharidosis (MPS) IIIB, IIIC and IIID). Our goal is to bring these treatments to market as quickly as possible. We are working with the leading academics and have engaged in a strategy of licensing key technologies to facilitate this goal.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access